ATE163422T1 - Anti-proliferative -und anti-inflammatorische verbindungen: 5- oder6-deoxyhexose monosaccharide die, in 5- oder 6-stellung einen, über das stickstoffatom gebundenen gesättigten stickstoffhaltigen heterozyklen, haben - Google Patents

Anti-proliferative -und anti-inflammatorische verbindungen: 5- oder6-deoxyhexose monosaccharide die, in 5- oder 6-stellung einen, über das stickstoffatom gebundenen gesättigten stickstoffhaltigen heterozyklen, haben

Info

Publication number
ATE163422T1
ATE163422T1 AT93900164T AT93900164T ATE163422T1 AT E163422 T1 ATE163422 T1 AT E163422T1 AT 93900164 T AT93900164 T AT 93900164T AT 93900164 T AT93900164 T AT 93900164T AT E163422 T1 ATE163422 T1 AT E163422T1
Authority
AT
Austria
Prior art keywords
containing heterocycle
proliferative
monosaccharides
compounds
deoxyhexose
Prior art date
Application number
AT93900164T
Other languages
German (de)
English (en)
Inventor
Sudershan K Arora
David S Thomson
M Nayeem Akhtar
Original Assignee
Boston Life Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boston Life Sciences Inc filed Critical Boston Life Sciences Inc
Application granted granted Critical
Publication of ATE163422T1 publication Critical patent/ATE163422T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/12—Acyclic radicals, not substituted by cyclic structures attached to a nitrogen atom of the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/24—Heterocyclic radicals containing oxygen or sulfur as ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
AT93900164T 1991-12-20 1992-12-18 Anti-proliferative -und anti-inflammatorische verbindungen: 5- oder6-deoxyhexose monosaccharide die, in 5- oder 6-stellung einen, über das stickstoffatom gebundenen gesättigten stickstoffhaltigen heterozyklen, haben ATE163422T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81090691A 1991-12-20 1991-12-20
US07/905,320 US5360792A (en) 1991-12-20 1992-06-29 Anti-proliferative and anti-inflammatory compounds: 5- or 6-deoxy hexose monosaccharides having a saturated nitrogen-containing heterocycle at the 5- or 6-position bound through the nitrogen atom

Publications (1)

Publication Number Publication Date
ATE163422T1 true ATE163422T1 (de) 1998-03-15

Family

ID=27123396

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93900164T ATE163422T1 (de) 1991-12-20 1992-12-18 Anti-proliferative -und anti-inflammatorische verbindungen: 5- oder6-deoxyhexose monosaccharide die, in 5- oder 6-stellung einen, über das stickstoffatom gebundenen gesättigten stickstoffhaltigen heterozyklen, haben

Country Status (12)

Country Link
US (1) US5360792A (OSRAM)
EP (1) EP0581916B1 (OSRAM)
JP (1) JPH06508152A (OSRAM)
CN (1) CN1077198A (OSRAM)
AT (1) ATE163422T1 (OSRAM)
CA (1) CA2104477A1 (OSRAM)
DE (1) DE69224520T2 (OSRAM)
FI (1) FI106863B (OSRAM)
IL (1) IL104112A (OSRAM)
NZ (1) NZ246305A (OSRAM)
TW (1) TW293013B (OSRAM)
WO (1) WO1993013117A2 (OSRAM)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5432163A (en) * 1992-11-13 1995-07-11 Greenwich Pharmaceuticals Incorporated Anti-proliferative and anti-inflammatory compounds: derivatives of pentose monosaccharides
CA2164827A1 (en) * 1993-06-11 1994-12-22 David S. Thomson Immunomodulatory, anti-inflammatory, and anti-proliferative compounds: 5,6-dideoxy, 5-amino derivatives of idose and 6-deoxy, 6-amino derivatives of glucose
US6329344B1 (en) * 1998-10-22 2001-12-11 Ranbaxy Laboratories Limited Derivatives of monosaccharides as cell adhesion inhibitors
AU771552B2 (en) 1999-02-05 2004-03-25 Alk-Abello A/S Novel mucosal delivery system
WO2005092907A2 (en) * 2004-03-26 2005-10-06 Ranbaxy Laboratories Limited Monosaccharide derivatives as anti-cancer and anti-inflammatory agents
WO2005100373A2 (en) * 2004-04-13 2005-10-27 Ranbaxy Laboratories Limited Monosaccharide derivatives as anti-cancer and anti-inflammatory agents
EP1768662A2 (en) * 2004-06-24 2007-04-04 Novartis Vaccines and Diagnostics, Inc. Small molecule immunopotentiators and assays for their detection
US20090221515A1 (en) * 2004-09-02 2009-09-03 Viswajanani Jitendra Sattigeri Monosaccharide derivatives
US20100113371A9 (en) * 2004-12-22 2010-05-06 Ranbaxy Laboratories Limited Inc. Derivatives Of Pentose Monosaccharides As Anti-Inflammatory Compounds
US20080114031A1 (en) * 2006-03-29 2008-05-15 Sattigeri Viswajanani J Monosaccharide derivatives
EP1864992A2 (en) * 2006-05-30 2007-12-12 Ranbaxy Laboratories, Ltd. Monosaccharide derivatives
US20080300196A1 (en) * 2006-10-03 2008-12-04 Ashwani Kumar Verma Monosaccharide derivatives

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2715121A (en) * 1950-09-09 1955-08-09 American Home Prod Alkyl sugar derivatives and their preparation
US3939146A (en) * 1973-03-01 1976-02-17 Strategic Medical Research Corporation Novel ethereal monosubstitutions of monosaccharide derivatives
US3965262A (en) * 1973-03-01 1976-06-22 Strategic Medical Research Corporation Method of enhancing learning and/or memory in warm blooded animals
US3939145A (en) * 1973-03-01 1976-02-17 Strategic Medical Research Corporation Novel ethereally monosubstituted monosaccharides
USRE30379E (en) * 1973-03-01 1980-08-19 Strategic Medical Research Corp. Ethereal monosubstitutions of monosaccharide derivatives
US4016261A (en) * 1973-03-01 1977-04-05 Strategic Medical Research Corporation Therapeutic composition and method of therapeutically treating warm blooded animals therewith
USRE32268E (en) * 1973-03-01 1986-10-21 Strategic Medical Research Corp. Therapeutic composition and method of therapeutically treating warm blooded animals therewith
US4056322A (en) * 1973-12-14 1977-11-01 Strategic Medical Research Corporation Preparation of ethers of monosaccharides
US4017608A (en) * 1973-12-14 1977-04-12 Strategic Medical Research Corporation Therapeutic composition and method of therapeutically treating warm blooded animals therewith
GB1589916A (en) * 1976-11-16 1981-05-20 Prodotti Antibiotici Spa Glucofuranose derivatives
USRE30354E (en) * 1978-02-17 1980-07-29 Strategic Medical Research Corp. Novel ethereally monosubstituted monosaccharides
USRE33000E (en) * 1981-01-12 1989-07-25 Greenwich Pharmaceuticals, Incorporated Therapeutic composition and method of treating viruses
US4738953A (en) * 1981-02-17 1988-04-19 Greenwich Pharmaceuticals Incorporated Method of therapeutically treating a warm blooded animal afflicted with an autoimmune disease and a synergistic composition therefor
US4735934A (en) * 1981-02-17 1988-04-05 Greenwich Pharmaceuticals Incorporated Method of therapeutically treating a warm blooded animal afflicted with an autoimmune disease
US4996195A (en) * 1989-01-09 1991-02-26 Greenwich Pharmaceuticals Inc. Derivatives of α,D-glucofuranose or α,D-allofuranose and intermediates for preparing these derivatives
US5010058A (en) * 1989-06-22 1991-04-23 501 Greenwich Pharmaceuticals Incorporated 3,5,6-substituted derivatives of 1,2-O-isopropylidene-α,D-glucofuranose and intermediates for preparing these derivatives
JPH06503813A (ja) * 1990-09-12 1994-04-28 グリニッチ　ファーマスューティカル，インコーポレイテッド 抗増殖活性および抗炎症活性を有するモノサッカライド，組成物およびその使用
IL100833A0 (en) * 1991-02-20 1992-09-06 Greenwich Pharma Method for synthesis of ethereally substituted blocked monosaccharides

Also Published As

Publication number Publication date
JPH06508152A (ja) 1994-09-14
CN1077198A (zh) 1993-10-13
TW293013B (OSRAM) 1996-12-11
IL104112A0 (en) 1993-05-13
EP0581916B1 (en) 1998-02-25
IL104112A (en) 1997-09-30
WO1993013117A2 (en) 1993-07-08
FI933654A0 (fi) 1993-08-19
AU665977B2 (en) 1996-01-25
CA2104477A1 (en) 1993-06-21
DE69224520T2 (de) 1998-07-23
NZ246305A (en) 1996-10-28
FI106863B (fi) 2001-04-30
DE69224520D1 (de) 1998-04-02
EP0581916A1 (en) 1994-02-09
FI933654L (fi) 1993-08-19
US5360792A (en) 1994-11-01
WO1993013117A3 (en) 1993-09-30
AU3249593A (en) 1993-07-28

Similar Documents

Publication Publication Date Title
ATE163422T1 (de) Anti-proliferative -und anti-inflammatorische verbindungen: 5- oder6-deoxyhexose monosaccharide die, in 5- oder 6-stellung einen, über das stickstoffatom gebundenen gesättigten stickstoffhaltigen heterozyklen, haben
Westermeyer Mental health for refugees and other migrants: Social and preventive approaches.
ATE246939T1 (de) Monoamid, diamid, thiol enthaltende metall- chelatierende verbindungen
BR9908610A (pt) Composto, processo para produzir o mesmo, composição farmacêutica, uso do composto, processos par ainibir a produção de óxido nìtrico e/ou citocina em mamìferos, e para impedir ou tratar doença cardìaca, doença autoimune ou choque séptico em mamìferos, e, pró medicamentos
FR2382232A1 (fr) Compositions cosmetiques de traitement des cheveux
ES2133324T3 (es) Compuestos de dibenzoxazepina sustituidos, composiciones farmaceuticas y metodos de uso.
ATE309249T1 (de) Chemokin rezeptor antagonisten und verwndung
DE3168595D1 (en) New para-substituted 3-phenoxy-1-alkylamino-propanol-2-s having beta receptor blocking properties
RU93053905A (ru) Оксипуриновые нуклеозиды и родственные им соединения, а также их ацильные производные для улучшения гемопоэза, фармацевтическая композиция и способ лечения и/или профилактики
DK0636027T3 (da) Angiotensin-II-antogonister mod sygdomme forbundet med forringet neuronal ledningshastighed, især diabetisk neuropati
UA27221C2 (uk) Ефіри циклогексеноноксиму та гербіцидний засіб
ATE47523T1 (de) Pharmazeutische zusammensetzungen.
DE69013787D1 (de) Ammonium-verbindung, diese enthaltende zusammensetzung und desinfektionsverfahren.
KR940702726A (ko) 치환된 퀴놀린-3-카르복시아미드 화합물의 용도 및 이를 이용한 다발성 경화증의 치료방법
DE69432593D1 (de) Immunomodulierende, entzündungshemmende und antiproliferative verbindungen:5,6-dideoxy, 5-aminoderivate von idose und 6-deoxy, 6-aminoderivate von glukose
WO1992004359A3 (en) Monosaccharides having anti-proliferation and anti-inflammatory activity, compositions and uses thereof
DE3367070D1 (en) Compositions comprising pepstatin and an histamine h2-receptor antagonist having an enhanced antiulcer activity
DK190983A (da) 2,4-diamino-5-(substituerede)pyrimidiner, fremgangsmaade til deres fremstilling og mellemprodukter derfor
ITRM920305A0 (it) Composizione farmaceutica per il trattamento dello shock, particolarmente dello shock cardiogeno e dello shock settico.
NO932959L (no) Antiprolifererende og antiinflammatoriske forbindelser: 5- eller 6-deoksyheksose-monosakkarider som har en mettet nitrogenholdig heterocyklus ved 5- eller 6-stillingen, bundet ved nitrogenatomet
ATE88634T1 (de) Arzneimittel zur behandlung von herzinsuffizienz.
FI951252A0 (fi) 10-substituoituja 1,8-dihydroksi-9(10H)antrakenonilääkeaineita
EP0324390A3 (de) Nigericinderivate, Verfahren zu deren Herstellung, diese enthaltende Mittel und Verwendung derselben sowie die Verwendung von Nigericin als antiviral wirksame Substanz
ATE241991T1 (de) Synergistische zusammensetzung, die daunorubicin derivate und antimetabolite enthält
EP0137439A3 (de) Antitumormittel

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties